91 related articles for article (PubMed ID: 20975272)
41. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
Coco B; Oliveri F; Maina AM; Ciccorossi P; Sacco R; Colombatto P; Bonino F; Brunetto MR
J Viral Hepat; 2007 May; 14(5):360-9. PubMed ID: 17439526
[TBL] [Abstract][Full Text] [Related]
42. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
Lai CL; Chien RN; Leung NW; Chang TT; Guan R; Tai DI; Ng KY; Wu PC; Dent JC; Barber J; Stephenson SL; Gray DF
N Engl J Med; 1998 Jul; 339(2):61-8. PubMed ID: 9654535
[TBL] [Abstract][Full Text] [Related]
43. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
Zhu R; Huang H; Zhang H; Wang Z; Hu X; Zhai W; Lin Y; Wang J; Zhu H
Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
[TBL] [Abstract][Full Text] [Related]
44. [Histological changes in the livers of chronic hepatitis B patients with persistently normal serum alanine transaminase levels].
Gui HL; Xie Q; Wang H; Cai W; Lin ZM; Jiang S; Xu P; Zhou XQ; Guo Q; Yu H
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):881-5. PubMed ID: 18171518
[TBL] [Abstract][Full Text] [Related]
45. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
[TBL] [Abstract][Full Text] [Related]
46. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
[TBL] [Abstract][Full Text] [Related]
47. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
Peng D; Han Y; Ding H; Wei L
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
[TBL] [Abstract][Full Text] [Related]
48. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.
Ni YH; Chang MH; Chen PJ; Tsai KS; Hsu HY; Chen HL; Tsuei DJ; Chen DS
Gastroenterology; 2007 Jun; 132(7):2340-5. PubMed ID: 17570209
[TBL] [Abstract][Full Text] [Related]
49. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
[TBL] [Abstract][Full Text] [Related]
50. [Relationship among pathological changes in liver tissues and level of serum ALT, virology of patients with chronic HBV infection].
Wang ZL; Liu WP; Wang GQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):388-90. PubMed ID: 19469184
[TBL] [Abstract][Full Text] [Related]
51. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.
Demirdag K; Yilmaz S; Ozdarendeli A; Ozden M; Kalkan A; Kilic SS
Hepatogastroenterology; 2003; 50(51):766-70. PubMed ID: 12828081
[TBL] [Abstract][Full Text] [Related]
52. Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
Cabrerizo M; Bartolomé J; Iñigo ER; López-Alcorocho JM; Cotonat T; Carreño V
J Med Virol; 1998 Dec; 56(4):294-9. PubMed ID: 9829632
[TBL] [Abstract][Full Text] [Related]
53. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
54. The clinical significance of persistently normal ALT in chronic hepatitis B infection.
Lai M; Hyatt BJ; Nasser I; Curry M; Afdhal NH
J Hepatol; 2007 Dec; 47(6):760-7. PubMed ID: 17928090
[TBL] [Abstract][Full Text] [Related]
55. [HBV DNA levels, aminotransferase and histological activity in young male patients with HBeAg positive chronic hepatitis B].
Cho SC; Lee SH; Shinn JJ; Han SH; Roh BJ; Sohn JH; Lee DH; Kee CS
Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):44-51. PubMed ID: 12499816
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
[TBL] [Abstract][Full Text] [Related]
58. Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B.
Fung J; Lai CL; Cheng C; Wu R; Wong DK; Yuen MF
Am J Gastroenterol; 2011 Mar; 106(3):492-6. PubMed ID: 21157442
[TBL] [Abstract][Full Text] [Related]
59. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
[TBL] [Abstract][Full Text] [Related]
60. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
Xie Y; Zhao H; Dai WS; Xu DZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
